Quantitative Systematic Strategies’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,230
| Closed | -$251K | – | 571 |
|
|
2020
Q1 | $251K | Sell |
2,230
-4,419
| -66% | -$497K | 0.21% | 174 |
|
|
2019
Q4 | $925K | Buy |
+6,649
| New | +$925K | 0.14% | 238 |
|
|
2019
Q2 | – | Sell |
-2,198
| Closed | -$259K | – | 468 |
|
|
2019
Q1 | $259K | Sell |
2,198
-2,518
| -53% | -$297K | 0.06% | 272 |
|
|
2018
Q4 | $295K | Sell |
4,716
-485
| -9% | -$30.3K | 0.07% | 418 |
|
|
2018
Q3 | $369K | Sell |
5,201
-229
| -4% | -$16.2K | 0.07% | 371 |
|
|
2018
Q2 | $361K | Buy |
+5,430
| New | +$361K | 0.07% | 421 |
|
|
2018
Q1 | – | Sell |
-6,714
| Closed | -$269K | – | 622 |
|
|
2017
Q4 | $269K | Buy |
+6,714
| New | +$269K | 0.07% | 426 |
|
|
2016
Q3 | – | Sell |
-11,925
| Closed | -$162K | – | 376 |
|
|
2016
Q2 | $162K | Buy |
+11,925
| New | +$162K | 0.08% | 377 |
|